Drug wars
by Robin Feldman · first published 2017
4mentions
4recommended by
4HN commenters
2017–2018first – last mentioned
100% recommend
"While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the
Affiliate links. As an Amazon Associate I earn from qualifying purchases.
For a fantastic discussion about the Byzantine process for generic drug approval, I recommend a recent episode of EconTalk[0]. The guest wrote a book called "Drug Wars: How Big Pharma Raises Prices and Keeps Generics off the Market"[1]. When up to half a billion dollars of revenue is at stake, the drug companies have incredible incentives to delay or prevent generics…
on “Fed Up with Drug Companies, Hospitals Decide to Start Their Own” ↗I would suggest anyone who is interested in reducing drug prices listen to this econtalk episode with Robin Feldman[0]. They discuss her book "Drug Wars how big pharma raises prices and keeps generics off the market"[1] In the episode they discuss all sorts of shenanigans that pharmaceutical companies pull. If you want real reform you need to look at…
on “The Best Fix for American Drug Prices Is Already on the Books” ↗Some of this insanity is covered nicely in the econlog podcast[1] on the book Drug Wars[2]. The NY Times always wants to throw all of the blame at insurers, but they are trying to save money. The generic system is a Kafakaesque set of regulations and processes. [1] http://www.econtalk.org/archives/2017/06/robin_feldman_o.htm...…
on “Some insurers insist that patients forgo generics and buy brand-name drugs” ↗The pharmaceutical industry is usually given as the prime example of an industry where patent protection is necessary; however, this is far from obvious. See Robin Feldman's book Drug Wars (there is an interview with her about it here: http//www.econtalk.org/robin-feldman-on-drug-patents-generics-and-drug-wars/)
on “The Case Against Patents (2013)” ↗